Prometheus Biosciences, Inc. Current Ratio 2021-2023 | RXDX
Prometheus Biosciences, Inc. current ratio from 2021 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-03-31 | $0.73B | $0.02B | 37.56 |
| 2022-12-31 | $0.71B | $0.02B | 31.04 |
| 2022-09-30 | $0.27B | $0.02B | 11.19 |
| 2022-06-30 | $0.22B | $0.02B | 13.32 |
| 2022-03-31 | $0.24B | $0.02B | 13.56 |
| 2021-12-31 | $0.27B | $0.02B | 16.14 |
| 2021-09-30 | $0.29B | $0.02B | 19.02 |
| 2021-06-30 | $0.31B | $0.02B | 17.61 |
| 2021-03-31 | $0.32B | $0.01B | 36.26 |
| 2020-12-31 | $0.06B | $0.02B | 3.77 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
